英文名稱 | Belimumab (Synonyms: LymphoStat B; Anti-TNFSF13B / BAFF / CD257) |
---|---|
中文名稱 | 貝利木單抗; 貝利尤單抗 |
CAS號 | 356547-88-1 |
分子量 | 144.54 kDa |
英文名稱 | Belimumab (Synonyms: LymphoStat B; Anti-TNFSF13B / BAFF / CD257) |
---|---|
中文名稱 | 貝利木單抗; 貝利尤單抗 |
CAS號 | 356547-88-1 |
分子量 | 144.54 kDa |
Belimumab (LymphoStat B) is a humanized IgG1λ monoclonal antibody against B-lymphocyte stimulator (BLyS) protein. Belimumab antagonizes BLyS activity in autoimmune diseases and B-lymphocyte malignancies. Belimumab can be used for systemic lupus erythematosus (SLE) research.